Bioventus Shares Rise After Improved 4Q

Dow Jones

Mar 11, 2025

By Chris Wack

Bioventus shares were up 27% to $11.10 after the company reported a fourth-quarter that saw improvement over the same quarter last year.

The company said its quarterly loss narrowed to $156,000, or 0 cents a share, from a loss of $6.1 million, or 10 cents a share, last year. Adjusted earnings per share were 15 cents, up from 7 cents in the prior year.

Sales for the quarter rose to $153.6 million, compared to last year's $135.4 million.

Bioventus said fourth-quarter cash from operations was $19.3 million, up 86.3% from last year.

For 2025, the company is expecting sales of $560 million to $570 million, compared to $573.3 million in 2024. It is also expecting adjusted earnings of 64 cents to 68 cents a share.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

March 11, 2025 10:31 ET (14:31 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2518629740"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2518629740\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2518629740?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-11 22:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2518629740","market":"sh","top_or_hot":-1,"title":"Bioventus Shares Rise After Improved 4Q","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Bioventus shares were up 27% to $11.10 after the company reported a fourth-quarter that saw improvement over the same quarter last year. \n</p>\n<p>\n  The company said its quarterly loss narrowed to $156,000, or 0 cents a share, from a loss of $6.1 million, or 10 cents a share, last year. Adjusted earnings per share were 15 cents, up from 7 cents in the prior year. \n</p>\n<p>\n  Sales for the quarter rose to $153.6 million, compared to last year's $135.4 million. \n</p>\n<p>\n  Bioventus said fourth-quarter cash from operations was $19.3 million, up 86.3% from last year. \n</p>\n<p>\n  For 2025, the company is expecting sales of $560 million to $570 million, compared to $573.3 million in 2024. It is also expecting adjusted earnings of 64 cents to 68 cents a share. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 11, 2025 10:31 ET (14:31 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioventus Shares Rise After Improved 4Q</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioventus Shares Rise After Improved 4Q\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-11 22:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Bioventus shares were up 27% to $11.10 after the company reported a fourth-quarter that saw improvement over the same quarter last year. \n</p>\n<p>\n  The company said its quarterly loss narrowed to $156,000, or 0 cents a share, from a loss of $6.1 million, or 10 cents a share, last year. Adjusted earnings per share were 15 cents, up from 7 cents in the prior year. \n</p>\n<p>\n  Sales for the quarter rose to $153.6 million, compared to last year's $135.4 million. \n</p>\n<p>\n  Bioventus said fourth-quarter cash from operations was $19.3 million, up 86.3% from last year. \n</p>\n<p>\n  For 2025, the company is expecting sales of $560 million to $570 million, compared to $573.3 million in 2024. It is also expecting adjusted earnings of 64 cents to 68 cents a share. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 11, 2025 10:31 ET (14:31 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2518629740","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2518629740","pubTimestamp":1741703460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Bioventus shares were up 27% to $11.10 after the company reported a fourth-quarter that saw improvement over the same quarter last year.The company said its quarterly loss narrowed to $156,000, or 0 cents a share, from a loss of $6.1 million, or 10 cents a share, last year. Adjusted earnings per share were 15 cents, up from 7 cents in the prior year.Sales for the quarter rose to $153.6 million, compared to last year's $135.4 million.Bioventus said fourth-quarter cash from operations was $19.3 million, up 86.3% from last year.For 2025, the company is expecting sales of $560 million to $570 million, compared to $573.3 million in 2024. It is also expecting adjusted earnings of 64 cents to 68 cents a share.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","BVS":"Bioventus Inc."},"translate_title":"Bioventus股价在第四季度改善后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BVS":1},"content_text":"By Chris Wack \n\n\n \n\n\n  Bioventus shares were up 27% to $11.10 after the company reported a fourth-quarter that saw improvement over the same quarter last year. \n\n\n  The company said its quarterly loss narrowed to $156,000, or 0 cents a share, from a loss of $6.1 million, or 10 cents a share, last year. Adjusted earnings per share were 15 cents, up from 7 cents in the prior year. \n\n\n  Sales for the quarter rose to $153.6 million, compared to last year's $135.4 million. \n\n\n  Bioventus said fourth-quarter cash from operations was $19.3 million, up 86.3% from last year. \n\n\n  For 2025, the company is expecting sales of $560 million to $570 million, compared to $573.3 million in 2024. It is also expecting adjusted earnings of 64 cents to 68 cents a share. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 10:31 ET (14:31 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}